MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

Mason-based AtriCure is projecting major revenue growth by 2030. Here's how its CEO said it plans to get there. Irish health ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Three years after she lost out on a state job to a candidate who’d received interview questions in advance from a friend ...

The company wrote, “our goal through this process has always been to provide a new contract that rewards you for your efforts ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to permanent cracks in the increasingly fragile research ecosystem, ...

His research group hoped it could develop into a treatment, or even a cure, for HIV.Castelli, who is Canadian, saw two career ...

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

Eric Schmidt-backed nonprofit FutureHouse is previewing an AI tool for 'data-driven' biology discovery, called Finch.

Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the ...

Techne's Q3 2025 earnings call, including 6% organic growth, FDA-driven opportunities, and strategies to tackle NIH funding & ...